Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: With special reference to age, body mass index, and HbA1c

Subjects with diabetes mellitus are considered to be at high risk of influenza infection and influenza-associated complications. To evaluate the immunogenicity of the influenza A(H1N1)pdm09 vaccine among these subjects, we performed a prospective cohort study and measured hemagglutination inhibition...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Vaccin Immunother
Egile Nagusiak: Egawa, Yumi, Ohfuji, Satoko, Fukushima, Wakaba, Yamazaki, Yuko, Morioka, Tomoaki, Emoto, Masanori, Maeda, Kazuhiro, Inaba, Masaaki, Hirota, Yoshio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2014
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896513/
https://ncbi.nlm.nih.gov/pubmed/24717236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28252
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak